Send the link below via email or IMCopy
Present to your audienceStart remote presentation
- Invited audience members will follow you as you navigate and present
- People invited to a presentation do not need a Prezi account
- This link expires 10 minutes after you close the presentation
- A maximum of 30 users can follow your presentation
- Learn more about this feature in our knowledge base article
Do you really want to delete this prezi?
Neither you, nor the coeditors you shared it with will be able to recover it again.
Make your likes visible on Facebook?
You can change this under Settings & Account at any time.
Transcript of Comparison Pharma
Try to preventing, alleviating or curing diseases
Improving diagnostic techniques.
Expand the position in attractive markets
Growth through innovation
Expand to emerging markets
Comparison in the Pharma Industry
Mathias Demleitner 543936
Regina Tello 543962
Maria Pedro Martí 537759
Pascal Moui 543964
Shayan Ravandoust 522479
Mikke Sundman 544066
Structure is divided to:
39.760 Mio. € Bayer Group
18.612 Mio. € Health Care
110.000 Bayer Group
55.300 Health Care
Founded in 1945
Largest mexican pharmaceutical company
Socially responsible company
Leading supplier to private hospitals
Currently has more than 14,000 employees
Satisfy the customers, through the development of Pharmaceutical Products and Medical Equipment.
Create high quality products
Use new technologies to impact the pharmaceutical sector
Reach international markets
- Founded in 1969
- Market leader
- Socially & Environmentally friendly
- 900 highly-qualified professionals
- Total sales of €335 million in 2012
- 5 product lines
Founded in 1917
Two business segments:
Turnover: 980 mil €
"Building well-being by being an innovative European R&D-based pharmaceutical and diagnostic company with a special emphasis on developing medicinal treatments and diagnostic tests for the global markets"
Growth of business operations through a competitive product portfolio
Strengthening the market position in Europe
Improving the flexibility and efficiency of operations
Founded in 1886
Owns hundreds of subsidiaries
Fortune 500 company (106)
Number of employees : 117,900
Revenue 2012 : 47,478 Mil €
To be responsible towards doctors, nurses, patients, our employees, our communities and our shareholders through the provision of high quality products and services.
Expand global reach through decentralized management approach
Focus on long term equity of brands, build customer loyalty
- Product: pharmaceuticals
- Price: Market specific
- Place: 50 countries
- Promotion: TV
Price: Market Specific
Place: Mexico and Latin America
Provide pharmaceutical solutions with high quality for the health and welfare of citizens
- Cinfa manage the entire process of medicines development
- Reinvests 90% of its profits in the company every year
Price: Depends on the country
Promotion: Sponsoring Football Team, TV, Radio
Product: pharmaceuticals and diagnostics
Price: Differs by market
Promotion: TV and radio
Product: Pharmaceuticals/ Medical Equipment
Price: Differs by country , in USA: within the CPI
Promotion: Advertising campaigns, Involvement in health initiatives
Founded on the 10th september of 1973
The first French pharmaceutical company and world number 5 in 2011.
Employees : 110 000
Turnover in 2012 : 35 billion of euros
This global group focused on seven main areas:
central nervous system,
•internal medicine and vaccines.
• To reposition Sanofi to ensure a more stable and sustainable growth in sales and earnings basis.
• Increasing its diversification and investing in seven growth platforms (Emerging Markets, support Diabetes, Vaccines, Consumer Health Care, Animal Health, New Genzyme and other Innovative Products).
• Be a world leader in healthcare with synergistic platforms
• Bringing innovative products to market
• Seize opportunities for value-added growth
• Adapt structures to meet the challenges and opportunities ahead
Product : pharmaceuticals
Price : it depends
Place : worldwide
Promotion : Tv, internet
Considering their active multinational presence, all of these companies must adapt to a similar arrangement of the marketing mix which generally includes:
Flexible market specific pricing
Major advertising campaigns
Standardized product lines adapted to specific markets
Due to the sensitivity of the use of medical materials and equipment and worldwide standards for such products, all of the target companies deploy similar marketing strategies along their value chain.
"In what way do these companies differ in their marketing strategies?"